To explore the safety, feasibility and clinical value of gynecological surgery in Da Vinci robot system.

Retrospective summary of Jilin Provincial Tumor Hospital in Oct.2014 to Feb. 2017 implementation of 151 cases of gynecological surgery clinical data and treatment.

151 patients were successfully completed surgery, no transfer to open and change the operation. 56 cases of hysterectomy, 29 cases of cervical cancer, 19 cases of endometrial cancer, 18 cases of uterine leiomyoma, 18 cases of ovarian tumor, 4 cases of breast cancer castration, 2 cases of unilateral appendiceal ovarian resection, 1 case of ovarian cancer, 1 case of vaginal cancer, 1 case of uterine total resection, 1 case of uterine fibroids + ovarian tumor nucleus, 1 case of uterine fibroids removed + retroperitoneal tumor resection. The operation time ranged from 38 - 280 min, the average (156.9 ± 119.6) min; intraoperative blood loss was 0 -120 ml, the average (64.9 ± 53.7) ml; postoperative intestinal function recovery time was 7-54 h, the average (31.4 ± 22.7) h; bladder function recovery time of 13-356 h, average (192.7±178.6) h; lymph node resection from 15 - 44, the average (28.4 ±12.7); hospitalization time was 89-648 h, the average (196.2 ± 73.4) h.

Da Vinci robotic surgical operating system is safe and feasible for gynecological surgery, especially in the obvious advantages of malignant tumors, patients with less bleeding, less trauma, quick recovery, high safety, with clinical value.